Business Wire

Vonage and C3 AI Partner on Network-Enabled, Agentic AI Field Services Solution for Mobile Workforces

11.2.2026 10:30:00 EET | Business Wire | Press release

Share

Vonage, part of Ericsson (NASDAQ: ERIC), today announced a strategic collaboration with C3 AI (NYSE: AI), a leading Enterprise AI application software provider, to launch C3 AI Field Services, a module of the C3 AI Asset Performance Suite of products, integrated with Vonage APIs. The AI-first module combines C3 AI’s powerful Enterprise AI capabilities with Vonage’s cutting-edge Communications APIs (Voice and Video) and Network APIs (Quality on Demand and Verify), to deliver superior performance, reliability and experiences for mobile enterprise field operations.

This collaboration builds on a broader network-powered solutions offering from Vonage where application-aware networking, including advanced connectivity capabilities such as Quality on Demand (QoD), can be applied to support critical field workflows. Quality on Demand is the first advanced network API being showcased¹ and represents one component of Vonage’s larger vision for network intelligence that aligns network behavior with application intent.

The global field service market focuses on managing and optimizing off-site workers, vehicles, and equipment for customer installations and repairs. Field service workers face challenges like complex equipment, fragmented information, skill shortages, non-real-time guidance, and diverse tools that contribute to delayed issue resolution, increased asset downtime, higher Total Cost of Ownership (TCO), and inconsistent operations and compliance.

The new C3 AI Field Services module, with Vonage APIs, tackles these historical challenges by equipping technicians with specialized mobile-first AI agents that provide real-time insights, step-by-step guidance, and seamless access to AI and human remote experts via voice and video — designed to drive improved first-time fix rates, support safety compliance, and accelerate skill development across distributed field teams.

“The future of work in mission-critical operations will be defined by intelligence embedded at the point of execution,” said Nikhil Krishnan, CTO, Data Science, C3 AI. “With Vonage, we’re extending our enterprise applications to support field technicians and engineers - helping organizations accelerate resolution, improve safety, and deliver consistent service at scale.”

C3 AI Field Services Module Capabilities

The C3 AI Field Services module coordinates multiple AI agents and specialized machine-learning models to handle complex tasks across a diverse set of data sources by quickly retrieving data, performing reasoning, and generating natural language summaries. These capabilities allow field technicians to be more productive and effective in their work by integrating intelligent assistance directly into daily workflows to make decisions about scheduling, safety, and troubleshooting at speed, while considering historical work order details and equipment specifications.

Enabling Next-Generation Field Efficiency Through Network APIs

Vonage’s advanced APIs power critical components of the C3 AI Field Services module, ensuring high-performance, secure, and reliable connectivity across field environments:

  • Secure and seamless login: Technicians working in challenging environments can login securely and effortlessly, without removing gloves or setting tools aside, thanks to Vonage Verify API that provides trusted and frictionless network-based verification.
  • Live field-grade AI assistance: Technicians can troubleshoot issues with a purpose-built AI assistant through a voice-based chat interface featuring noise cancellation. Leveraging Vonage Voice APIs allows the AI assistant to detect speech accurately for reliable performance, even in rugged, crowded and noisy environments.
  • Remote video assistance: When a human is needed in the loop, for providing guidance or validation, the technician has the option to collaborate live with a remote expert via a video call with consistent HD quality enhancing experience on both ends and improving first-time-fix rates. This is enabled by Vonage’s Video and Quality on Demand APIs that deliver reliable, high network performance despite the technician operating in areas of significant network congestion.
  • Knowledge management: To address the challenge of a fragmented knowledge base and facilitate upskilling of new workers, the solution has features for knowledge aggregation and video archival. Technicians can swiftly download instruction and best practice videos from different enterprise systems, and upload HD videos and AI summaries for training, quality, compliance and proof of completion. Vonage’s Quality on Demand API is designed to deliver superior performance, reliability, and user experiences, to reduce resolution times, enhance technician efficiency, and accelerate the onboarding of new team members.

“Together with C3 AI, we’re redefining the future of field services by equipping technicians with trusted, mobile-first AI agents and reliable connectivity,” said Christophe Van de Weyer, President and Head of Business Unit API at Vonage. “As a leader in network-powered solutions, Vonage is driving the next generation of AI-first, business-critical enterprise applications. This partnership highlights the transformative potential of Quality on Demand and real-time network intelligence, setting new standards for trust, safety, and innovation in enterprise solutions.”

The joint solution is currently available for demo. Vonage and C3 AI will showcase the C3 AI Field Services module at the Ericsson VIP Zone during Mobile World Congress (MWC) in Barcelona, taking place from March 2–5, 2026. Find out more and book a meeting here. The solution will also be featured at C3 AI’s flagship C3 Transform event in Florida, taking place from March 3–5, 2026.

Learn more about Vonage Communications and Network APIs.

¹Tested in a lab environment.

About Vonage

Vonage, a part of Ericsson, creates technology that empowers enterprises and equips developers to lead in the next era of digital transformation. Its AI-powered platforms and tools enable new value creation and innovative customer experiences across mobile networks and the cloud.

The company's technology portfolio includes Network APIs, CPaaS, CCaaS, and UCaaS solutions. Trusted by enterprises across industries and embraced by developers around the world, Vonage is committed to reimagining every digital interaction.

Vonage is a wholly-owned subsidiary of Ericsson (NASDAQ: ERIC) and operates within Ericsson Group Business Area Global Communications Platform (BGCP). For more information visit www.vonage.com and follow @Vonage.

Copyright © 2025 Vonage. All rights reserved. VONAGE®, the V logo, and other Vonage marks are registered trademarks of Vonage or its affiliates in the United States and other countries.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260211428340/en/

Contacts

Press Contact: press@vonage.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

www.businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Galderma Receives U.S. FDA Approval for Differin ® Epiduo ® Acne Gel Prescription-to-OTC Switch22.5.2026 19:25:00 EEST | Press release

Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) use in ages 12 years and older, marking a significant Prescription-to-OTC transition in acne care. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522074280/en/ The U.S. FDA approves Differin® Epiduo® Acne Gel Prescription-to-OTC switch This milestone represents yet another example of Galderma’s unique Integrated Dermatology strategy, demonstrating how proven innovations from its Therapeutic Dermatology portfolio can further strengthen its Dermatological Skincare offerings. The Prescription‑to‑OTC transition highlights Galderma’s scale and expertise in successfully commercializing dermatology innovations across the full spectrum of acne care. With the appro

Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 17:18:00 EEST | Press release

Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522186975/en/ Adam Plich, CEO and Co-Founder of Avanzanite Bioscience. “Thalassaemia is a complex, chronic and multisystem disease characterised by anaemia, ineffective erythropoiesis and haemo

ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 15:30:00 EEST | Press release

OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future

Enhertu ® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 15:00:00 EEST | Press release

Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority

Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 14:45:00 EEST | Press release

Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, signalling a shift in health systems from late-stage treatment to earlier intervention. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522587414/en/ Selected from 393 submissions across 68 countries, the winning teams were recognised through the inaugural ‘Future Health Challenge 2026: Building Anticipatory Health Systems through Population Sensing’, delivered by Future Health – A Global Initiative by Abu Dhabi in collaboration with MIT Solve. Health systems globally are facing rising costs and persistent delays in diagnosis, with many conditions still identified only after symptoms become severe. At the sam

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye